The role of integrins in the formation of the placental increment (placenta accreta spectrum)

Abstract

One of the most serious pregnancy complications is currently considered as a violation of cytotrophoblast invasion, particularly, a pathologically increased depth of invasion, leading to the formation of the placental increment (placenta accreta), ingrowth (placenta increta), and germination (placenta percreta). Cytotrophoblast invasion is regulated through subtle intercellular interactions, an important role among which is played by integrins, transmembrane glycoproteins that contribute to the immersion of cytotrophoblast in the endometrium and myometrium. The balance disturbance in the expression of α1β1, α5β1, and α6β4 integrins after normal implantation form a pathological extravillous trophoblast (EVT) phenotype by the blastocyst. This review examines the importance of integrins, collagens, and fibronectin in the formation of placental ingrowth (placenta accreta spectrum).

Keywords

cytotrophoblast / integrins / placenta accreta spectrum / pregnancy / cytotrophoblast invasion

References

[1] Lash GE, Ernerudh J. Decidual cytokines and pregnancy complications: focus on spontaneous miscarriage. J Reprod Immunol. 2015;108:83–89. doi: 10.1016/j.jri.2015.02.003

[2] Lash G.E., Ernerudh J. Decidual cytokines and pregnancy complications: focus on spontaneous miscarriage // J Reprod Immunol. 2015. Vol. 108. P. 83–89. doi: 10.1016/j.jri.2015.02.003

[3] Damsky CH, Librach C, Lim KH, et al. Integrin switching regulates normal trophoblast invasion. Development. 1994;120(12):3657–3666.

[4] Damsky C.H., Librach C., Lim K.H., et al. Integrin switching regulates normal trophoblast invasion // Development. 1994. Vol. 120, N 12. P. 3657–3666.

[5] Silver RM, Barbour KD. Placenta Accreta Spectrum. Accreta, Increta, and Percreta. Obstet Gynecol Clin North Amer. 2015;42(2):381–402.

[6] Silver R.M., Barbour K.D. Placenta Accreta Spectrum. Accreta, Increta, and Percreta // Obstet Gynecol Clin North Amer. 2015. Vol. 42, N 2. P. 381–402.

[7] Mehrabadi A, Hutcheon JA, Liu S, et al. Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage. Obstet Gynecol. 2015;125(4):814–821. doi: 10.1097/AOG.0000000000000722

[8] Mehrabadi A., Hutcheon J.A., Liu S., et al. Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage // Obstet Gynecol. 2015. Vol. 125, N 4. P. 814–821. doi: 10.1097/AOG.0000000000000722

[9] Irving C, Hertig AT. A study of placenta accrete. Surg Gynecol Obstet. 1937;64:178–200.

[10] Irving C., Hertig A.T. A study of placenta accreta // Surg Gynecol Obstet. 1937. Vol. 64. P. 178–200.

[11] Fox H. Placenta accreta: 1945–1969. Obstet Gynecol Surv. 1972;27(7):475–490.

[12] Fox H. Placenta accreta: 1945–1969 // Obstet Gynecol Surv.1972. Vol. 27, N 7. P. 475–490.

[13] Benirschke K, Burton GJ, Baergen RN. Pathology of the human placenta. 6th ed. Berlin: Springer-Verlag; 2012.

[14] Benirschke K., Burton G.J., Baergen R.N. Pathology of the human placenta. 6th ed. Berlin : Springer-Verlag, 2012.

[15] Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012;33(4):244–251. doi: 10.1016/j.placenta.2011.11.010

[16] Jauniaux E., Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease // Placenta. 2012. Vol. 33, N 4. P. 244–251. doi: 10.1016/j.placenta.2011.11.010

[17] Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218(1):75–87. doi: 10.1016/j.ajog.2017.05.067

[18] Jauniaux E., Collins S., Burton G.J. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging // Am J Obstet Gynecol. 2018. Vol. 218, N 1. P. 75–87. doi: 10.1016/j.ajog.2017.05.067

[19] D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;42:509–517. doi: 10.1002/uog.13194

[20] D’Antonio F., Iacovella C., Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis // Ultrasound Obstet Gynecol. 2013. Vol. 42. P. 509–517. doi: 10.1002/uog.13194

[21] Flo K, Widnes C, Vårtun Å, Acharya G. Blood flow to the scarred gravid uterus at 22–24 weeks of gestation. BJOG. 2014;121:210–215. doi: 10.1111/1471-0528.12441

[22] Flo K., Widnes C., Vårtun Å., Acharya G. Blood flow to the scarred gravid uterus at 22–24 weeks of gestation // BJOG. 2014. Vol. 121. P. 210–215. doi: 10.1111/1471-0528.12441

[23] Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27–36. doi: 10.1016/j.ajog.2017.02.050

[24] Jauniaux E., Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis // Am J Obstet Gynecol. 2017. Vol. 217, N 1. P. 27–36. doi: 10.1016/j.ajog.2017.02.050

[25] Strizhakov AN, Ignatko IV, Davydov AI. Obstetrics: textbook. Moscow: GEOTAR-Media; 2020. (In Russ). doi: 10.33029/9704-5396-4-2020-AKU-1-1072

[26] Стрижаков А.Н., Игнатко И.В., Давыдов А.И. Акушерство: учебник. Москва : ГЭОТАР-Медиа, 2020. doi: 10.33029/9704-5396-4-2020-AKU-1-1072

[27] Knöfler M. Critical growth factors and signaling pathways controlling human trophoblast invasion. Int J Dev Biol. 2010;54(2–3):269–280. doi: 10.1387/ijdb.082769mk

[28] Knöfler M. Critical growth factors and signaling pathways controlling human trophoblast invasion // Int J Dev Biol. 2010. Vol. 54, N 2–3. P. 269–280. doi: 10.1387/ijdb.082769mk

[29] Plaisier M. Decidualization and angiogenesis. Best Pract Res Clin Obstet Gynaecol. 2011;25:259–271. doi: 10.1016/j.bpobgyn.2010.10.011

[30] Plaisier M. Decidualization and angiogenesis // Best Pract Res Clin Obstet Gynaecol. 2011. Vol. 25. P. 259–271. doi: 10.1016/j.bpobgyn.2010.10.011

[31] Ailamazyan EK, Stepanova OI, Selkov SA, Sokolov DI. Cells of Immune System of Mother and Trophoblast Cells: Constructive operation for the Sake of Achievement of the Joint Purpose. Annals of the Russian academy of medical sciences. 2013;11:12–21. (In Russ).

[32] Айламазян Э.K., Степанова O.И., Сельков С.A., Соколов Д.И. Клетки иммунной системы матери и клетки трофобласта: «Конструктивное сотрудничество» ради достижения совместной цели // Вестник Российской Aкадемии Meдицинских Наук. 2013. Т. 11. С. 12–21.

[33] Tarrade A, Lai Kuen R, Malassiné A, et al. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab Invest. 2001;81(9):1199–1211. doi: 10.1038/labinvest.3780334

[34] Tarrade A., Lai Kuen R., Malassiné A., et al. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta // Lab Invest. 2001. Vol. 81, N 9. P. 1199–1211. doi: 10.1038/labinvest.3780334

[35] Weitzner O, Seraya-Bareket C, Biron-Shental T, et al. Enhanced expression of αVβ3 integrin in villus and extravillous trophoblasts of placenta accrete. Arch Gynecol Obstet. 2021;303(5):1175–1183. doi: 10.1007/s00404-020-05844-4

[36] Weitzner O., Seraya-Bareket C., Biron-Shental T., et al. Enhanced expression of αVβ3 integrin in villus and extravillous trophoblasts of placenta accreta //Arch Gynecol Obstet. 2021. Vol. 303, N 5. P. 1175–1183. doi: 10.1007/s00404-020-05844-4

[37] Gupton SL, Riquelme D, Hughes-Alford SK, et al. Mena binds α5 integrin directly and modulates α5β1 function. J Cell Biol. 2012;198(4):657–676. doi: 10.1083/jcb.201202079

[38] Gupton S.L., Riquelme D., Hughes-Alford S.K., et al. Mena binds α5 integrin directly and modulates α5β1 function // J Cell Biol. 2012. Vol. 198, N 4. P. 657–676. doi: 10.1083/jcb.201202079

[39] Carusi DA. The placenta accreta spectrum: Epidemiology and risk factors. Clin Obstet Gynecol. 2018;61(4):733–742. doi: 10.1097/GRF.0000000000000391

[40] Carusi D.A. The placenta accreta spectrum: Epidemiology and risk factors // Clin Obstet Gynecol. 2018. Vol. 61, N 4. P. 733–742. doi: 10.1097/GRF.0000000000000391

[41] Bachmann M, Kukkurainen S, Hytönen VP, Wehrle-Haller B. Cell adhesion by integrins. Physiol Rev. 2019;99(4):1655–1699. doi: 10.1152/physrev.00036.2018

[42] Bachmann M., Kukkurainen S., Hytönen V.P., Wehrle-Haller B. Cell adhesion by integrins // Physiol Rev. 2019. Vol. 99, N 4. P. 1655–1699. doi: 10.1152/physrev.00036.2018

[43] Knöfler M, Haider S, Saleh L, et al. Human placenta and trophoblast development: key molecular mechanisms and model systems. Cell Mol Life Sci. 2019;76(18):3479–3496. doi: 10.1007/s00018-019-03104-6

[44] Knöfler M., Haider S., Saleh L., et al. Human placenta and trophoblast development: key molecular mechanisms and model systems // Cell Mol Life Sci. 2019. Vol. 76, N 18. P. 3479–3496. doi: 10.1007/s00018-019-03104-6

[45] Factor EG, Bonagura TW, Babischkin JS, et al. Prematurely elevating estradiol in early baboon pregnancy suppresses uterine artery remodeling and expression of extravillous placental vascular endothelial growth factor and α1β1 and α5β1 integrins. Endocrinology. 2012;153(6):2897–2906. doi: 10.1210/en.2012-1141

[46] Factor E.G., Bonagura T.W., Babischkin J.S., et al. Prematurely elevating estradiol in early baboon pregnancy suppresses uterine artery remodeling and expression of extravillous placental vascular endothelial growth factor and α1β1 and α5β1 integrins // Endocrinology. 2012. Vol. 153, N 6. P. 2897–2906. doi: 10.1210/en.2012-1141

[47] Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011;90(10):1140–1146. doi: 10.1111/j.1600-0412.2011.01147.x

[48] Tikkanen M., Paavonen J., Loukovaara M., Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss // Acta Obstet Gynecol Scand. 2011. Vol. 90, N 10. P. 1140–1146. doi: 10.1111/j.1600-0412.2011.01147.x

[49] Hecht JL, Baergen R, Ernst LM, et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol. 2020;33(12):2382–2396. doi: 10.1038/s41379-020-0569-1

[50] Hecht J.L., Baergen R., Ernst L.M., et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel // Mod Pathol. 2020. Vol. 33, N 12. P. 2382–2396. doi: 10.1038/s41379-020-0569-1

RIGHTS & PERMISSIONS

Eco-Vector